Circulating Tumor Cell Market – A Comprehensive Study Backed by Real-Time Insights

The global circulating tumor cell market is projected to grow at a strong CAGR of 12.10% and to reach value USD 9.78 billion between 2023 and 2030, according to Market Research Future (MRFR). It defines tumor cells as cells that travel through the vascular system and are responsible for forming tumor. Circulating tumor cells can also be found near tumor sites, in thrombi, and in bone marrow.

MRFR report provides comprehensive coverage of the circulating tumor cells market from market overview, market numbers, market CAGR, industry outlook, market segmentation, geographical coverage, market forecast, and companies profiled for the research report.

Tumor cells develop the capability to circulates through the blood vessels and can cause tumor at distant sites, they are termed as circulating tumor cells (CTC). Identification of these cells in blood samples can be used as marker for various cancer. They can play important role in cancer diagnosis and prognosis. CTC are easily isolated and used for drug testing and to observe the response of various therapies. Presence of tumor cells in blood taken from patient as non-invasive way which helps in early diagnosis of cancer and also its assessment of treatment response.

Advancement in technologies have made the process of isolation, detection and analysis of CTC easier and faster than traditional methods. CellSearch system is the only FDA-approved system for capturing and analyzing CTC. Other organizations such as Menarini, Clearbridge BioMaster, Microfluidics are working in the industry to develop automated CTC isolation devices.

Market Overview

The global Circulating Tumor Cell Market is expected to register remarkable growth during the assessment period, states MRFR. Over the years, the need for a trusted method to assess drug response has been on the rise, thus, spurring the uptake of CTC. On the other hand, the need to detect and analyze cancer to determine the treatment methods is expected to bolster the uptake of CTC during the review period.

The presence of noninvasive cancer detection and analysis technologies is anticipated to fuel market expansion over the forecast period. Additionally, the presence of automated CTC isolation devices is expected to drive market expansion.

Explore In-depth Details: Circulating Tumor Cell Market Research Report

Segmentation

The global Circulating Tumor Cell Market has been segmented based on technology, application, end-user, and region.

By technology, the market has been divided into immuno-magnetic cell separation, microfluidic-based platforms, and automated cell separation platforms.

By application, the Circulating Tumor Cell Market has been classified into prostate cancer, breast cancer colorectal cancer, Gynae cancer, melanoma and others.

By end-user, the market has been segmented into clinical laboratories, research laboratories, and academic and government research institutes

Regional Analysis

Geographically, the market has been divided into the Americas, Europe, Asia-Pacific (APAC), the Middle East and Africa, and South America.

It is anticipated that the Americas would experience exponential expansion due to the availability of a robust healthcare infrastructure. An increase in the number of cancer patients is contributing to the expansion of the regional market. The United States holds the largest market share, followed by Canada and Mexico.

Europe is anticipated to dominate the market due to its advanced healthcare infrastructure and rising adoption of technology innovations. This is accelerating the expansion of the market for circulating tumor cells. Additionally, a greater emphasis on research and development activities is boosting market expansion in the region.

APAC is anticipated to record the highest growth rate over the evaluation period. The presence of a burgeoning healthcare infrastructure and a large population are driving the market expansion in the region. Increasing disposable wealth and the prevalence of a sizable cancer population are also contributing to the market's expansion.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com